Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PARAGON BIOSCIENCES, LLC via PARAGON BIOSCIENCES, LLC
2021 · third_quarter · Q3
Issues related to public and private investment in biosciences and R&D
Issues related to public and private investment in biosciences and R&D
Source: Senate LDA
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
2021 · second_quarter · Q2
Issues related to public and private investment in biosciences and R&D
Issues related to public and private investment in biosciences and R&D
PARAGON BIOSCIENCES, LLC via PARAGON BIOSCIENCES, LLC
2021 · first_quarter · Q1
Issues related to public and private investment in biosciences and R&D
Issues related to public and private investment in biosciences and R&D
PARAGON BIOSCIENCES, LLC via PARAGON BIOSCIENCES, LLC
2020 · fourth_quarter · Q4
Issues related to public and private investment in biosciences and R&D
Issues related to public and private investment in biosciences and R&D
PARAGON BIOSCIENCES, LLC via PARAGON BIOSCIENCES, LLC
2020 · third_quarter · Q3
Issues related to public and private investment in biosciences and R&D
Issues related to public and private investment in biosciences and R&D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARAGON BIOSCIENCES, LLC via PARAGON BIOSCIENCES, LLC
2020 · second_quarter · Q2
Issues related to public and private investment in biosciences and R&D
Issues related to public and private investment in biosciences and R&D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARAGON BIOSCIENCES, LLC via PARAGON BIOSCIENCES, LLC
2020 · first_quarter · Q1
Issues related to public and private investment in biosciences and R&D
Issues related to public and private investment in biosciences and R&D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARAGON BIOSCIENCES, LLC via PARAGON BIOSCIENCES, LLC
2019 · fourth_quarter · Q4
Issues related to public and private investment in biosciences and R&D
Issues related to public and private investment in biosciences and R&D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARAGON BIOSCIENCES, LLC via PARAGON BIOSCIENCES, LLC
2019 · third_quarter · Q3
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARAGON BIOSCIENCES, LLC via PARAGON BIOSCIENCES, LLC
2019 · third_quarter · RR
Issues related to public and private investment in biosciences and research and development
Issues related to public and private investment in biosciences and research and development